YamaguchiJ, BodelleP, VallariAS, et al.: HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. AIDS Res Hum Retroviruses, 2004; 20:944–957.
2.
PlantierJC, LeozM, DickersonJE, et al.: A new human immunodeficiency virus derived from gorillas. Nat Med, 2009; 15:871–872.
3.
GaoF, BailesE, RobertsonDL, et al.: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature, 1999; 397:436–441.
4.
AghokengAF, Mpoudi-NgoleE, DimodiH, et al.: Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PloS One, 2009; 4:e7702.
5.
SedaghatAR, RastegarDA, O'ConnellKA, DinosoJB, WilkeCO, and BlanksonJN: T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clin Infect Dis, 2009; 49:1763–1766.
6.
BaileyJR, ZhangH, WegweiserBW, et al.: Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape. J Infect Dis, 2007; 196:50–55.
7.
TebitDM, LobritzM, LalondeM, et al.: Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: Impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol, 2010; 84:9817–9830.
8.
DescampsD, CollinG, LetourneurF, et al.: Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. J Virol, 1997; 71:8893–8898.
9.
PyneMT, KonnickEQ, PhansalkarA, and HillyardDR: Evaluation of the Abbott investigational use only realtime HIV-1 assay and comparison to the Roche Amplicor HIV-1 monitor test, version 1.5. J Mol Diagnost: JMD, 2009; 11:347–354.
10.
DeaconNJ, TsykinA, SolomonA, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science, 1995; 270:988–991.
11.
BuckheitRW3rd, SalgadoM, MartinsKO, and BlanksonJN: The implications of viral reservoirs on the elite control of HIV-1 infection. Cell Mol Life Sci: CMLS, 2013; 70:1009–1019.
12.
HerspergerAR, MiguelesSA, BettsMR, and ConnorsM: Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control. Curr Opin HIV AIDS, 2011; 6:169–173.
13.
EmuB, SinclairE, HatanoH, et al.: HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol, 2008; 82:5398–5407.
